Clinical Trial Update: Histidine Therapy: A Project to Treat HARS Deficiency [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial update for histidine therapy targeting HARS deficiency (HARS Syndrome).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hars Syndrome

Drugs mentioned

• Histidine therapy (histidine)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: HARS Syndrome | Phase 2, Phase 3 | Status: UNKNOWN